Wexford Capital »

Beam Therapeutics shares owned by Wexford Capital

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Wexford Capital

Quarter filed Position value Share count Share price at filing
2025-06-30 $246k 15k 17.01
2021-12-31 $926k 12k 79.65

More positions owned by Wexford Capital

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Mammoth Energy Svcs (TUSK)
Sunococorp Com Shs Llc (SUNC)
Nephros (NEPH)
Acm Resh Com Cl A (ACMR)
New Amer Acquisition I Corp Unit 99/99/9999 (NWAX.U)
Republic Awys Hldgs Com Shs (RJET)
Comcast Corp Cl A (CMCSA)
Greenfire Res Com Shs (GFR)
Century Aluminum Company (CENX)
Energy Transfer Com Ut Ltd Ptn (ET)
Enterprise Products Partners (EPD)
Acuren Corporation (TIC)
Avadel Pharmaceuticals Com Shs (AVDL)
Haymaker Acquisition Corp Iv Class A (HYAC)

View all positions for Wexford Capital

Top funds holding Beam Therapeutics

ARK Investment Management
FMR
Farallon Capital Management
Vanguard Group
BlackRock
State Street Corporation
Arch Venture Corp
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Kynam Capital Management
Geode Capital Management
MWG Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas
Casdin Capital

View all funds holding Beam Therapeutics